H. Lundbeck A Logo

H. Lundbeck A

HLUN | XCSE

Overview

Corporate Details

ISIN(s):
DK0061804697 (+5 more)
LEI:
5493006R4KC2OI5D3470
Country:
Denmark
Address:
Ottiliavej 9, 2500 Valby
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research and today our products are available in more than 100 countries. We are tirelessly dedicated to restoring brain health, so every person can be their best.  Research into the brain costs more, takes longer and fails at a higher rate than most other medical research. But with brain disorders sharply on the increase, it’s more important than ever. We are one of the only global pharmaceutical companies solely focused on the brain, and our research programs tackle some of the most complex challenges in neuroscience. Our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-02-21 13:27
Related Party Transactions
English 124.1 KB
2025-02-21 13:27
Related Party Transactions
English 29.9 KB
2025-02-05 16:40
Related Party Transactions
English 134.1 KB
2025-02-05 16:40
Related Party Transactions
English 96.6 KB
2025-02-05 07:46
Annual Report
English 6.4 MB
2025-02-05 07:46
Annual Report
English 2.9 KB
2025-02-05 07:46
Annual Report (ESEF)
English 13.1 MB
2025-02-05 07:24
Annual Report
English 33.3 KB
2025-02-05 07:24
Earnings Release
English 443.0 KB
2025-02-04 17:11
Inside Information Statement
English 17.0 KB
2025-02-04 17:11
Inside Information Statement
English 99.1 KB
2025-01-09 14:07
Inside Information Statement
English 29.4 KB
2025-01-09 14:07
Inside Information Statement
English 95.4 KB
2024-11-28 07:56
Inside Information Statement
English 114.8 KB
2024-10-31 12:44
Earnings Release
English 30.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Camurus Logo Camurus Sweden CAMX
Cannabotech Ltd. Logo Cannabotech Ltd. Israel CNTC
Canzon Israel Ltd. Israel CNZN
CATALYST MEDIA GROUP PLC Logo CATALYST MEDIA GROUP PLC United Kingdom CMX
Celon Pharma S.A. Logo Celon Pharma S.A. Poland CLN
Chemical Works of Gedeon Richter Plc Logo Chemical Works of Gedeon Richter Plc Hungary RICHT
COSMO Pharmaceuticals N.V. Logo COSMO Pharmaceuticals N.V. Netherlands (Kingdom of the) COPN
DanCann Pharma A/S Logo DanCann Pharma A/S Denmark DANCAN
DARWIN AG Logo DARWIN AG Germany 7V0
Dechra Pharmaceuticals PLC Logo Dechra Pharmaceuticals PLC United Kingdom DPH